CDC Real-Time RT-PCR Support Strategies and Updates 3 lab/MAY25 900AM PAHO... · H3 or pdm H1 (+)...

transcript

•The findings and conclusions in this presentation are those of the author(s) and do not necessarily represent the views of the Centers for Disease Control and Prevention

Stephen Lindstrom, Ph.D.

Diagnostics Development Team Virus Surveillance and Diagnosis Branch

Influenza Division Centers for Disease Control and Prevention

Fourth Annual SARInet Meeting

May 23-26, 2017

Punta Cana, Dominican Republic

•National Center for Immunization and Respiratory Diseases

•Influenza Division

CDC Real-Time RT-PCR Support Strategies and Updates

Overview

Testing strategies & algorithms for surveillance and

diagnostic testing

CDC rRT-PCR assays for detection and

characterization of influenza

Support strategies for rRT-PCR testing

CLSIS – protocols/procedures

IRR - Reagent kits, control materials

A(H1N1)pdm09 reactivity and assay update

Influenza Viruses in Humans - 2017

Potential Pandemic strains

Avian H7

Avian H5

Avian H9

Type A

Seasonal Strains

Type B

1918 1957 1968 1977 1997

1998/9

Avian H6

Avian H10

Routine Surveillance

No Known risk for avian influenza

Perform RT-PCR testing for seasonal human influenza A and influenza B viruses

InfA (+)

• InfA unsubtypable – possible

novel influenza

• Based on risk

assessment, test for

H5, H7 and/or other

novel strains w/RT-PCR

• InfA inconclusive samples

with possible SOIV

• Inconclusive samples with

possible coinfection/LAIV

InfA (+)

H3 or pdm H1 (+)

InfB (+)

Test for YAM, VIC

Report Results

Test for H3, pdm

H1, pdmInfA

Negative

Report Results

Routine Influenza Testing Algorithm

InfB (+)

YAM or VIC (+)

Report Results

Influenza Detection Algorithm and Sample Flow

CDC Influenza Virus Real-time RT-PCR Reagent Kits

Influenza A H5 (Asian lineage)

Subtyping Panel

(InfA, H5a, H5b, RP)

Influenza A Subtyping Panel

(InfA, H3, pdmH1, pdmInfA)

Influenza A/B Typing

(InfA, Inf B, RP)

Influenza B genotyping Panel

(InfB, YAM, VIC, RP)

Influenza A

EuH7 Assay

(EuH7)

CDC Human Influenza Real-Time RT-PCR Diagnostic Panel

Kit Contents Application

Influenza A Subtyping Kit

(Ver2) FluIVD03-6

Primer and Probe Sets: InfA, H3, pdmInfA, pdmH1, RP

Controls: SIPC

Specifically detects and differentiates seasonal influenza subtypes H3 and H1pdm09

Detects classical swine influenza viruses and swine triple reassortant viruses

Update: CDC Influenza A/Subtyping Kit (Ver2)

• Update pdmH1 assay to ensure reactivity (Clade 6B.1) • Remove H1 assay • Update positive control – SIPC • Qualify ZEN quenched probes

Reactivity of Updated pdmH1 assay -

Inclusivity

Strain designation Conc

. InfA pdmInfA

A/California/04/09 10 2.9 (3/3) (3/3) (3/3)

A/California/07/09 10 3.5 (3/3) (3/3) (3/3)

A/Colorado/14/2012 10 2.1 (3/3) (3/3) (3/3)

A/Florida/27/2001 10 2.9 (3/3) (3/3) (3/3)

A/Florida/62/2014 10 2.2 (3/3) (3/3) (3/3)

A/Maryland/13/2012 10 2.0 (3/3) (3/3) (3/3)

A/Minnesota/03/2011 10 2.9 (3/3) (3/3) (3/3)

A/North

Carolina/4/2014 10 2.3 (3/3) (3/3) (3/3)

A/Utah/13/2016 10 2.5 (3/3) (3/3) (3/3)

A/Washington/24/2012 10 2.5 (3/3) (3/3) (3/3)

Interpretation of Real-time

RT-PCR Results

InfA H3 pdm InfA

pdmH1 B RP Result

+ + - - - +/- A/H3

+ - + + - +/- A/H1pdm

- - - - + +/- B

- - - - - + Negative

- - - - - - Inconclusive

+ - - - - + Influenza A - Unsubtypable

Potential novel influenza

+ - + + - ±

Influenza A detected;

Presumptive positive for Influenza A(H3N2) variant virus

Strain Designation sub-type Lineage Invitrogen Quanta

InfA EuH7 InfA EuH7

A/ANHUI/1/2013 H7N9 Eu1 + + + +

A/DUCK/VIETNAM/NCVD-197/2009 H7N3 Eu + + + +

A/TURKEY/ITALY/5425/07 H7N3 Eu + + + +

A/Shoveler/Egypt/00017-NAMRU3/2007

H7N3 Eu + + + +

A/Mallard/Netherlands/12/2000 H7N3 Eu + + + +

A/Chicken/Italy/5074/1999 H7N1 Eu + + + +

A/MEXICO/7218/2012 H7N3 N.Am.2 + Undet + Undet

1Eu = Eurasian lineage; 2N.Am. = North American lineage.

Reactivity of CDC EuH7 Assay

Support for Public Health and

Research Laboratories

Reagent ordering - IRR

www.internationalreagentresource.org

CDC rRT-PCR Influenza Kit Distribution Globally

as of 4th April 2017 in 117 countries

CDC Influenza Virus Real-time RT-PCR Panel (RUO) Catalogue#

Shipped

Influenza A/B Typing Panel FluRUO-01 261 209 276 77

Influenza A (H1/H3/H1 pdm09) Subtyping Panel FluRUO-04 139 146 86 0

Influenza A (H3/H1pdm09) SubtypingPanel (VER 2) FluRUO-09 127 58

Influenza B Lineage Genotyping Panel FluRUO-05 101 111 140 43

Influenza A(H5) (Asian Lineage) Subtyping Panel (VER 3) FluRUO-06,

FluRUO-08 80 83 121 21

Influenza A/H7 (Eurasian Lineage) Assay FluRUO-07 58 59 86 20

Total 639 608 836 219

Countries receiving CDC rRT-PCR reagents

117 countries

CDC rRT-PCR Influenza Kit Distribution to PAHO

Countries

as of 17 May 2017

27 laboratories in 22 countries

CDC Influenza Virus Real-time RT-PCR Panel (RUO) Catalogue#

Shipped

Influenza A/B Typing Panel FluRUO-01 33 38 41 21

Influenza A (H1/H3/H1 pdm09) Subtyping Panel FluRUO-04 26 22 21 0

Influenza A (H3/H1pdm09) Subtyping Panel (VER 2) FluRUO-09 12 15

Influenza B Lineage Genotyping Panel FluRUO-05 26 16 27 8

Influenza A(H5) (Asian Lineage) Subtyping Panel (VER 3) FluRUO-06,

FluRUO-08 10 9 18 3

Influenza A/H7 (Eurasian Lineage) Assay FluRUO-07 10 9 15 4

Total 105 94 134 51

PAHO countries receiving reagents from IRR - 2017

27 laboratories in 22 countries

CDC Sharepoint Site for Laboratory

Support for Influenza Surveillance

Provide public health and research laboratories access to multiple assays, procedures and methods depending on need (equipment, chemistry, etc.)

Allow for coordinated communication with registered laboratories

Provide timely notification of assay updates

www.cdc.gov/flu/clsis

>320 users

Countries registered on CLSIS

90 countries

PAHO countries registered on CLSIS - 2017

46 registrants

19 countries

• Real-time rRT-PCR laboratory protocols for influenza

• English, Spanish, Portuguese

• RNA extraction procedures (manual & automated)

• Package inserts for kits and controls

• Enzyme options

• Real-time PCR equipment options

• Primer/probe sequence information

• Manufacturing options for probe chemistry

(ZEN, BHQ)

UPDATES:

• Updated rRT-PCR procedures

• Assay specific protocols for FluA subtyping and FluB genotyping.

• Package insert for updated FluA subtyping kit (Ver2)

• Assay sequence updates to pdmH1 primers/probe

• FluB YAM/VIC genotyping primer/probe sequences

PENDING UPDATES:

• Real-time PCR equipment procedures

• Qiagen Rotorgene Assay Manager protocol

• Automated Nucleic Acid isolation procedures

• Qiagen EZ1 Advanced XL

• Roche MP96

• FluB YAM/VIC genotyping primer/probe sequences

ONGOING ASSAY DEVELOPMENT:

• rRTPCR assays

• N. Am. H7

• N. Am H5

• FluB genotyping – possible update

• Diagnostic sequencing

• Targeted Sanger sequencing for genotype identification

• H1pdm09 vs H1v genotypes

• Human H3 vs H3v genotypes

• B VIC deletion mutation variant

PAHO countries receiving

support from CDC - 2017

Support provided Countries

Received IRR reagents 22

Registered on CLSIS

(protocols) 19 (46 users)

Countries that submitted

samples to CDC since 2014 38

Total Countries in Region 46

Qualification of Real-time PCR Dx Instruments and Nucleic Acid

Extraction Platforms

Real-time PCR Platforms

BioRad iCycler iQ4/ iQ5

LifeTechnologies/ABI 7300~7500Fast

Qiagen Corbett Rotor-Gene Stratagene/Agilent Mx3000p/3005p

Roche LC 480

Roche LC 2.0

BioRad CFX

LifeTechnologies/ABI Step One

Roche LC Nano

Roche LC 96

LifeTechnologies – ViiA7/QuantStudio Dx

BioRad MiniOpticon 3M Integrated Cycler

Real-time PCR Platforms

7500Fast/FastDx Rotor-Gene

Mx3005p LC 480

Step One

LC Nano LC 96

QuantStudio 3/5

Integrated Cycler

? Thermo

QuantStudio

Qiagen

BioRad

Agilent

3M Roche

FDA cleared Real-time PCR Platforms Under Evaluation for Dx Qualification

72 well Assay set up locked Results analysis and reporting locked

Thermo – ABI QuantStudio Dx (QSDX) Qiagen RotorGene Dx – (QMDX)

96 well Assay set up locked Results analysis and reporting locked

Automated Nucleic Acid Extraction

Magnapure Compact

Qiagen Qiacube

EasyMag EZ1 Advanced XL

Magnapure 96

Kingfisher Roche

Qiagen

Qiasymphony Qiacube HT

Magnapure LC

BioMerieux

Qiagen Extraction Platforms

QIAextractor: 8-96 samples per run.

Qiacube: Purification of NA from up to 12 samples; spin-column format

EZ1 Advanced XL: Purification of nucleic acids from 1-6 or 1-14 samples

QIAsymphony: processing 1-96 samples - in batches of 24

“kingfisher”

Magnetic bead extraction system Flexible format allows for multiple chemistry options Chemistry setup necessary Pre/post sample processing necessary Various platform throughputs – 1-15; 24, 96

Multiple vendors – Fisher Scientific, Ambion MagMax, Promega, etc.

Diagnostic Extraction Platform Under Evaluation

1-14 samples 20-40 minutes Reagents pre-packaged – no set up Tube-to-tube extraction – no post extraction processing GMP manufacturing for Dx testing

8-96 samples Reagents pre-packaged – no set up Plate-to-plate extraction –pre/post extraction processing GMP manufacturing for Dx testing

Qiagen EZ1 Advanced XL Roche Magnapure 96

Extraction Platforms Under Consideration

Qiagen Qiasymphony

KingFisher

Diagnostics Development Team

Lakshmi Malapati

LaShondra Berman

Bo Shu

Christine Warnes

Janna Murray

Ji Liu

Shannon Emery

Marisela Rodriguez

Brian Lynch

Kai-Hui Wu

Acknowledgements EPB:

Lenee Blanton Desiree Mustaquim OD: Becky Garten Battelle Team: Stephen Burke (Project Manager) Janna Murray (IVD Product support) Chantelle Runnels (Quality Control) Kellie White (Quality Assurance) OD/IRR Team: Erica Guthrie Sarah Schildecker DSR: Nicky Sulaiman Kanwar Bedi Dennis Bagarozzi

No Man is an island

Thank You

CDC Real-Time RT-PCR Support Strategies and Updates 3 lab/MAY25 900AM PAHO... · H3 or pdm H1 (+)...

Documents